You are here
Future COVID variants will likely reinfect us multiple times a year, experts say — unless we invest in new vaccines
Primary tabs
For more than a year now, the original COVID-19 vaccines have held up remarkably well — even miraculously so — against a Greek alphabet of new variants: Alpha, Beta, Gamma, Delta.
But now experts say something is changing. Since the start of 2022, the initial version of Omicron, known as BA.1, has been spinning off new sublineages — BA.2, BA.2.12.1, BA.4, BA.5 — at an alarming pace.
Earlier variants did this, too. But it never really mattered, because their offshoots “had no functional consequence,” according to Eric Topol, founder of Scripps Translational Institute. “They did not increase transmissibility or pathogenicity.”
Today’s rapidly proliferating Omicron mutants are different, however. They all have one worrisome trait in common: They’re getting better and better at sidestepping immunity and sickening people who were previously shielded by vaccination or prior infection.
The virus, in other words, is now evolving faster — and in a more consequential way — than ever before. Given the increasing speed of immune evasion — and what this pattern portends for the future — experts warn that the time has come to rethink our reliance on the vaccine status quo and double down on next-generation vaccines that can actually stop infection.
“As difficult it is to mentally confront, we must plan on something worse than Omicron in the months ahead,” Topol wrote Sunday. “We absolutely need an aggressive stance to get ahead of the virus — for the first time since the pandemic began — instead of surrendering.”
...
Recent Comments